Quick answers
- What is Xylocaine-Mpf with Epi?
- Xylocaine-Mpf with Epi is a brand name of Lidocaine hydrochloride,epinephrine bitartrate, a prescription medicine. The FDA NDC Directory lists 1 Xylocaine-Mpf with Epi product in 1 strength and form.
- Who makes Xylocaine-Mpf with Epi?
- Fresenius Kabi USA holds the FDA application for Xylocaine-Mpf with Epi (NDA006488, approved November 19, 1948).
- Is there a generic or store brand of Xylocaine-Mpf with Epi?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Xylocaine-Mpf with Epi product. Ask your pharmacist whether one is right for you.
- Has Xylocaine-Mpf with Epi been recalled?
- No recall linked to Xylocaine-Mpf with Epi products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Xylocaine-Mpf with Epi is
Each Xylocaine-Mpf with Epi product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Lidocaine hydrochloride,epinephrine bitartrate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| epinephrine bitartrate 0.005 mg/mL · lidocaine hydrochloride anhydrous 20 mg/mL injection, solution (epidural, infiltration, intracaudal, perineural) | Xylocaine-Mpf with Epi | 3 products, 3 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Lidocaine hydrochloride,epinephrine bitartrate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA006488 | Fresenius Kabi USA | November 19, 1948 | 1 |
Companies that list Xylocaine-Mpf with Epi
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Xylocaine-Mpf with Epi products.
Recalls
No recall linked to Xylocaine-Mpf with Epi products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.